IBDINSPIRE CORPORATE BOND ETF
INSPIRE CORPORATE BOND ETF
$23.17+0.52% vs prior close
232452-WK
Price through Oct 20, 2026 · Flows through unavailable. Figures use the latest available records, not a live quote. Fund details retrieved Oct 20, 2026. Holdings snapshot retrieved Oct 20, 2026.
IBD price
Source: Market tape, daily closes; price return, distributions not reinvested
Table
| Date | IBD close |
|---|---|
| Sep 21, 2026 | $23.33 |
| Sep 22, 2026 | $23.34 |
| Sep 23, 2026 | $23.17 |
| Sep 24, 2026 | $23.20 |
| Sep 25, 2026 | $23.06 |
| Sep 28, 2026 | $23.00 |
| Sep 29, 2026 | $23.02 |
| Sep 30, 2026 | $23.00 |
| Oct 1, 2026 | $23.01 |
| Oct 2, 2026 | $23.02 |
| Oct 5, 2026 | $23.01 |
| Oct 6, 2026 | $23.12 |
| Oct 7, 2026 | $23.05 |
| Oct 8, 2026 | $23.05 |
| Oct 9, 2026 | $23.17 |
| Oct 12, 2026 | $23.06 |
| Oct 13, 2026 | $23.06 |
| Oct 14, 2026 | $23.15 |
| Oct 15, 2026 | $23.19 |
| Oct 16, 2026 | $23.23 |
| Oct 19, 2026 | $23.05 |
| Oct 20, 2026 | $23.17 |
The desk’s read
Recent fund-flow records are unavailable, while the price has returned -4.3% so far this year.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
$360Massets under management
—expense ratio
—net flow, trailing month
101Kavg daily volume, 30 days
247holdings · US-domiciled
2024listed March 10, 2024 · beta 0.11
Sector weights
- Cash & Others100%
- Other100%
- Corporate99.14%
- Industrial68.37%
- Financial22.28%
- Utility9.35%
- Cash0.86%
Source: Portfolio composition, latest disclosure
Show as table
| Item | Value (%) |
|---|---|
| Cash & Others | 100% |
| Other | 100% |
| Corporate | 99.14% |
| Industrial | 68.37% |
| Financial | 22.28% |
| Utility | 9.35% |
| Cash | 0.86% |
Performance
| 1 week | -0.3% |
| 1 month | -0.7% |
| 3 months | -2.0% |
| 6 months | -3.4% |
| YTD | -4.3% |
| 1 year | -4.9% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
Net flows
| 1 week | — |
| 1 month | — |
| 3 months | — |
| YTD | — |
| 1 year | — |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
The risk read
6%realized volatility, 30 days (annualized)
4%realized volatility, 1 year
-5.6%deepest fall from a peak, 1 year
-4.9%latest close versus that peak
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
The case against IBD
Due diligence cuts both ways. These funds sit on the same shelf and beat IBD on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.5B | +$2.3B | 343× the assets · +$2.3B in over the month | Head-to-head |
| SGOV iShares 0-3 Month Treasury Bond ETF | 0.07% | $113.5B | +$6.2B | 315× the assets · +$6.2B in over the month | Head-to-head |
| IJR iShares Core S&P Small-Cap ETF | 0.06% | $104.3B | +$383M | 290× the assets · +$383M in over the month | Head-to-head |
| BIL State Street SPDR Bloomberg 1-3 Month T-Bill ETF | 0.14% | $50.8B | +$1.2B | 141× the assets · +$1.2B in over the month | Head-to-head |
| IUSB iShares Core Total USD Bond Market ETF | 0.06% | $48.1B | +$5.2B | 134× the assets · +$5.2B in over the month | Head-to-head |